logo
Select company
Select metric
14.28%Capital Expenditures to Operating Cash Flow
VS
Market
67
Sector
65
Industry
52
History
79
$ 3.44Close
$ 1.06 - $ 6.77 52-Week Range
Ticker Information

Ticker

CPIX

Company Name

CUMBERLAND PHARMACEUTICALS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

CUMBERLAND PHARMACEUTICALS INC - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CPIX - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 1.02M14.28%$ 7.12M
3/31/2025$ 1.35M24.89%$ 5.42M
12/31/2024$ 179.71K0%$ -612.19K
9/30/2024$ 239.62K0%$ -1.48M
6/30/2024$ 286.78K0%$ -715.64K
3/31/2024$ 336.78K6.27%$ 5.38M
12/31/2023$ 453.05K7.43%$ 6.09M
9/30/2023$ 2.01M23.09%$ 8.69M
6/30/2023$ 2.13M21.11%$ 10.09M
3/31/2023$ 2.21M30.71%$ 7.19M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CUMBERLAND PHARMACEUTICALS INC's latest trailing twelve months (TTM) CapEx/OCF stands at 41.66%.
  • Over the past 5 years, CUMBERLAND PHARMACEUTICALS INC's average CapEx/OCF has been 18.96%.
  • The median CapEx/OCF for CUMBERLAND PHARMACEUTICALS INC during this period was 21.11%
  • CUMBERLAND PHARMACEUTICALS INC reached its highest CapEx/OCF over the past 5 years at 41.66%.
  • The lowest CapEx/OCF recorded by CUMBERLAND PHARMACEUTICALS INC in the same timeframe 5.59%

CUMBERLAND PHARMACEUTICALS INC's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
SRTS : SENSUS HEALTHCARE INC 2.08%BFRI : BIOFRONTERA INC -IMCC : IM CANNABIS CORP 0.47%CTSO : CYTOSORBENTS CORP -SBFM : SUNSHINE BIOPHARMA INC -FLGC : FLORA GROWTH CORP -MYO : MYOMO INC -ECOR : ELECTROCORE INC -AYTU : AYTU BIOPHARMA INC -MRSN : MERSANA THERAPEUTICS INC -

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: CapEx [ $ 2.26M ] / CF - Operations [ $ 5.42M ]
(=) CapEx/OCF [ 41.66% ]

CPIX - Capital Expenditures to Operating Cash Flow, Last 5 years

5.59%

Minimum

Dec 31, 2021

41.66%

Maximum

Sep 30, 2020

18.96%

Average

21.11%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.81% with a standard deviation of 29.51%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.81%
median22.42%
std29.51%